Evoqua Water Technologies said it will present technical information about its type-approved SeaCURE Ballast Water Management System and applicability to newbuilds and retrofits at the Posidonia International Shipping Exposition in Athens, Greece.
Evoqua Regional Manager Dimitrios Tsoulos will present “SeaCURE BWMS. Safety and Reliability Comes with Experience. Evoqua Water Technologies’ Answer to the Ballast Water Treatment Challenge.” from 11 a.m.-1:30 p.m. Thursday, June 5 in Posidonia Seminar Room 2. Tsoulos has worked in the water treatment industry for almost 10 years and is a certified project manager.
Tsoulos will be joined by Lars Nupnau, who led the development and certification of the SeaCURE Ballast Water Management System.
The SeaCURE system utilizes a patented process that first injects biocide into ballast seawater before it reaches the large surface filter intakes to reduce the growth of marine organisms that can clog the filters. Next, Chloropac concentric tubular electrodes (CTE) generate sodium hypochlorite from the natural salinity in sea water which eliminates the need to purchase biocides and store or replenish them onboard. The SeaCURE system also features low energy requirements and low maintenance costs due to the self-cleaning feature of the CTE technology. Proprietary control logic monitors the biocide dose level necessary to provide the required efficacy depending on ballast water conditions. Chloropac electrodes have been proven in more than 2,500 installations worldwide over the past 40 years.
The efficacy of the SeaCURE Ballast Water Management System is in accordance with International Maritime Organization (IMO) Convention D-2 regulations and exceeds the G8 and G9 Guidelines for Approval of Ballast Water Management Systems. In February 2014, the Federal Maritime and Hydrographic Agency of Germany (Bundesamt für Seeschifffahrt und Hydrographie- BSH) granted type approval for the SeaCURE system which concludes the international approval process that began with the basic approval and then final approval granted by the IMO in 2012.
Testing of the SeaCURE system was successfully completed at three separate installations each with widely differing ecosystems. Land based testing has also been undertaken at GSI and MERC; two independent test facilities that are today U.S. Coast Guard (USCG)-approved Independent Laboratories. Evoqua is well positioned to achieve US Coast Guard Type Approval on an expedited basis based on a submittal of existing data.